Rx/reimbursement adult incontinence in Norway demonstrated steady volume growth in 2025, reaching 13 million units, with an annual growth rate of 2%. In value terms, the category reached NOK33 million in 2025, rising by 4% compared to the previous year, which signals not only robust demand but also successful premiumisation and value capture, despite broader regional and global economic pressures. This performance reflects a continuation of the upward trajectory observed over previous years and
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Norway with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Norway, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Norway report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Norway?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Norway?
- How are products distributed in Rx/Reimbursement adult incontinence in Norway?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Norway - Category analysis
Key Data Insights
Manufacturers Drive Value Perception through Performance, Innovation and Efficacy
Manufacturers Drive Value Perception through Performance, Innovation and Efficacy
Manufacturers Enhance Care Outcomes with Tailored Convenience Solutions
Manufacturers to Advance Sustainable Solutions as Ageing Population Drives Uptake
Essity Integrates Carbon Reduction into Product and Packaging Innovation
Institutional Supply Routes Maintain Dominance as Procurement Centralises
Tissue and Hygiene in Norway - Industry Overview
Brands Turn Nappies into Lifestyle Essentials and Drive Premium Value
Key Data Insights
Brands Turn Nappies into Lifestyle Essentials and Drive Premium Value
Convenience and Efficacy Aids Premium-Driven Growth
Sustainability Continues to Grow as a Defining Trend in the Industry
Consumer Engagement to Grow with Limited Editions and Seasonal Designs
Brands to Boost Sustainability Credentials to Attract Eco-Conscious Buyers
Discounters and Variety Stores to Continue Gaining Ground as Consumers Trade Down for Value
Metsä Tissue Leverages Lambi Product Innovation to Defend Share as Private Label Gains Ground
Discounters Continue to Expand Their Reach and Attract Value-Focused Shoppers
E-Commerce and Omnichannel Innovation Accelerates Online Retail Growth
Country Reports Disclaimer
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!